REMEVi, a LegitScript-certified telehealth platform, now charges $96 a month for compounded semaglutide and $168 for tirzepatide on its 12-month plan, one price at every dose, with clinician review, required labs and shipping, in English or Spanish.

LAS VEGAS — November 11, 2026 — REMEVi, a bilingual telehealth platform for GLP-1 weight-loss care, has lowered its prices for compounded semaglutide and tirzepatide. Compounded semaglutide now starts at $96 a month on the 12-month plan, or $143 month-to-month. Compounded tirzepatide starts at $168 a month on the 12-month plan, or $224 month-to-month. The prices apply to new plans started on or after November 10, 2026, and are published in full at remevihealth.com/pricing and in Spanish at remevihealth.com/es/precios.

Cost is the most common barrier to this kind of care. In a KFF Health Tracking Poll published in November 2025, 56% of adults who had used a GLP-1 medication said it was difficult to afford, and 14% said they had stopped because of the cost. Language is a second barrier: more than 40 million people in the United States speak Spanish at home, according to the U.S. Census Bureau, and the CDC’s most recent national survey (August 2021 to August 2023) puts adult obesity prevalence at 44.0% among Hispanic adults, compared with 40.3% for all adults.

“Price and language are the two things that keep people out of this kind of care,” said Blake Chapman, co-founder of REMEVi. “When the medication costs too much, people look for shortcuts. When nobody on the other end speaks your language, you are guessing about your own treatment. We lowered our prices and kept everything else the same: a licensed clinician reviews every patient, the pharmacies are state-licensed and named on our site, and all of it works in Spanish as well as it does in English.”

REMEVi GLP-1 prices as of November 10, 2026 (USD)

• Compounded semaglutide injection: $96 a month on the 12-month plan ($1,248 today), $118 a month on the 6-month plan ($708 today), $125 a month on the 3-month plan ($375 today), or $143 month-to-month.
• Compounded tirzepatide injection: $168 a month on the 12-month plan ($2,184 today), $199 a month on the 6-month plan ($1,194 today), $215 a month on the 3-month plan ($645 today), or $224 month-to-month.
• Compounded oral semaglutide: $163 a month on the 6-month plan ($978 today), $170 a month on the 3-month plan ($510 today), or $215 month-to-month.

A plan month is one 28-day supply. The 3-, 6- and 12-month plans are paid up front. The 12-month plan is a 52-week term with 13 fills.

What every plan includes

• One price at every dose. The price does not rise when the dose does.
• An evaluation by a licensed clinician, who decides whether treatment is appropriate, and clinician-guided dose changes.
• Labs when the clinician requires them, injection supplies where they apply, and shipping.
• No membership fee.
• Care coordination in English or Spanish, from the health questionnaire through refills.

Safeguards

• REMEVi is LegitScript certified (certification ID 50384507).
• A prescription is required. Every patient is reviewed by a clinician licensed in the patient’s state.
• Medications are prepared by state-licensed U.S. 503A compounding pharmacies, which REMEVi names on its website.
• Available in 49 states and Washington, D.C. Not available in Louisiana.

Common questions

How much does compounded semaglutide cost at REMEVi?
From $96 a month on the 12-month plan ($1,248 paid up front), $118 a month on the 6-month plan, $125 a month on the 3-month plan, or $143 month-to-month.

How much does compounded tirzepatide cost at REMEVi?
From $168 a month on the 12-month plan ($2,184 paid up front), $199 a month on the 6-month plan, $215 a month on the 3-month plan, or $224 month-to-month.

How much does compounded oral semaglutide cost at REMEVi?
From $163 a month on the 6-month plan ($978 paid up front), $170 a month on the 3-month plan, or $215 month-to-month.

Does the price go up at higher doses?
No. Each plan is one price at every dose and at every renewal.

Is there a membership or consultation fee?
No. The plan price covers the clinician evaluation, the medication if prescribed, required labs and shipping.

Can care be provided in Spanish?
Yes. The website, the health questionnaire, messages and care coordination are available in Spanish and English, at the same prices.

Is compounded semaglutide or tirzepatide FDA-approved?
No. Compounded medications are not FDA-approved. They are prepared by state-licensed pharmacies for an individual patient on a clinician’s prescription.

About REMEVi

REMEVi is a bilingual telehealth platform based in Las Vegas, Nevada, offering GLP-1 weight-loss care and clinician-prescribed wellness therapies in English and Spanish. It was founded in 2026 by Blake Chapman and Danai Del Carmen Chapman and is operated by REMEVi LLC. REMEVi is LegitScript certified and serves patients in 49 states and Washington, D.C.

Compounded medications are not FDA-approved. A prescription is required, and a licensed clinician decides whether treatment is appropriate. Plans renew at the same price until canceled. Prices are in U.S. dollars and were current on November 10, 2026.

Media Contact:
Name: Blake Chapman
Company: REMEVi
Email: care@remevihealth.com
Phone: (702) 352-4746
Website: https://remevihealth.com